Chlamydia pneumoniae and atherosclerosis

@article{Belland2004ChlamydiaPA,
  title={Chlamydia pneumoniae and atherosclerosis},
  author={Robert J. Belland and Scot P. Ouellette and Jens Gieffers and Gerald I. Byrne},
  journal={Cellular Microbiology},
  year={2004},
  volume={6}
}
Exposure to Chlamydia pneumoniae is extremely common, and respiratory infections occur repeatedly among most people. Strong associations exist between C. pneumoniae infection and atherosclerosis as demonstrated by: (i) sero‐epidemiological studies showing that patients with cardiovascular disease have higher titres of anti‐C. pneumoniae antibodies compared with control patients; (ii) detection of the organism within atherosclerotic lesions, but not in adjacent normal tissue by… Expand
Could Chlamydia Pneumoniae Be Considered an Infectious Risk Factor for Inflammatory Diseases Such as Atherosclerosis ?
TLDR
The spectrum of cell biological, animal, and human clinical data suggests that C. pneumoniae may be considered an infectious risk factor for atherosclerosis but further studies are needed to clarify the etiopathogenetic role of C. tuberculosis in atherosclerotic vessel walls. Expand
Higher incidence of persistent chronic infection of Chlamydia pneumoniae among coronary artery disease patients in India is a cause of concern
TLDR
A significant presence of C. pneumoniae was detected in heavy smokers, non-alcoholics and with family histories of diabetes and blood pressure group of CAD patients by nPCR, indicating synergistic association of C pneumoniae infection and development of CAD with other risk factors. Expand
The association of Chlamydia pneumoniae infection with atherosclerosis: Review and update of in vitro and animal studies.
TLDR
Investigating the exact role of this infection in causing atherosclerosis may be helpful in controlling the disease, and there is evidence that Cpn can increase the impact of the classical risk factors such as hyperlipidemia, pro-inflammatory cytokines, and smoking for atheros sclerosis. Expand
Effects of Chlamydia Pneumoniae Infection on Inflammation and Lipid Parameters in Humans and Mice
TLDR
The present study investigated the effect of acute C. pneumoniae infection and the infection-induced pulmonary inflammatory response and changes in serum lipid metabolism in mice and developed a new diagnostic method for cLPS, a sensitive and specific enzymeimmunoassay (EIA) method for the measurement of serum chlamydial lipopolysaccharide (cLPS) concentration. Expand
Chlamydia pneumoniae in Carotid Artery Atherosclerosis: A Comparison of Its Presence in Atherosclerotic Plaque, Healthy Vessels, and Circulating Leukocytes From the Same Individuals
TLDR
The authors' observation of >80% incidence of C pneumoniae in atherosclerotic plaques of the carotid artery does not prove causality between an infection with the pathogen and the development of atherosclerosis, but given the structural and functional differences between veins and arteries, careful interpretation of the results regarding a possible causative role of C influenza seems warranted. Expand
Pathogens and atherosclerosis: update on the potential contribution of multiple infectious organisms to the pathogenesis of atherosclerosis.
TLDR
The strength of the data for individual or groups of pathogens with regard to atherosclerosis pathogenesis and their potential contribution by direct or indirect mechanisms are evaluated and whether the established associations are supportive of the infectious disease paradigm is discussed. Expand
Interactions between Chlamydia pneumoniae and trace elements
TLDR
The pattern of trace element changes was essentially similar regardless of positive makers of C. pneumoniae, suggesting a similar etiopathogenesis in both subgroups, and a new possible link to this infection in aortic sclerosis. Expand
Chlamydophila pneumoniae and endothelial activation: the smoke that precedes the fire of atherosclerosis?
  • S. Didion
  • Biology, Medicine
  • Circulation research
  • 2008
TLDR
The first evidence linking C pneumoniae infection and atherosclerosis was obtained from the finding that individuals with coronary heart disease and acute myocardial infarction were found to posses significantly higher titers of C pneumoniaE –specific IgG antibodies than that in individuals without cardiovascular disease. Expand
Chlamydia pneumoniae infection in patients with carotid artery disease
TLDR
High titers of specific IgG and IgA, which can indicate reinfection or exacerbation of chronic infection, occur statistically more frequent in CAD patients compared to healthy controls and there is an urgent need of standardization of PCR methods detecting DNA Chlamydia pneumoniae in atherosclerotic plaques. Expand
Impact of viral and bacterial infections in coronary artery disease patients
TLDR
The association of ath-erosclerosis with different infectious agents, specifically Chlamydia pneumoniae, Helicobacter pylori, Herpes viruses and periodontal pathogens are described and cited in this review. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 100 REFERENCES
Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries.
TLDR
Findings support the seroepidemiologic studies and offer further evidence that C. pneumoniae may be involved in the atherosclerotic process. Expand
Does Chlamydia pneumoniae cause coronary heart disease?
  • T. Quinn
  • Medicine
  • Current opinion in infectious diseases
  • 1998
TLDR
Although a causal effect has not been proved, the relationship between Chlamydia pneumoniae and atherosclerosis continues to grow and to stimulate more definitive studies. Expand
Background and current knowledge of Chlamydia pneumoniae and atherosclerosis.
  • J. Grayston
  • Biology, Medicine
  • The Journal of infectious diseases
  • 2000
TLDR
Attributes of Chlamydia pneumoniae of potential importance to a relationship with Atherosclerosis are described and the conclusive demonstration of an association of C. pneumoniae and atherosclerosis by the repeated and frequent finding of the organism in atherosclerotic tissue is demonstrated. Expand
Chlamydia pneumoniae and atherosclerosis: links to the disease process.
TLDR
The presence of C pneumoniae causes macrophage foam cell formation and lipid oxidation with murine and human cells cocultured in the presence of LDL, and evidence that implicates 2 putative chlamydial virulence factors in the development of these pathologic processes is provided. Expand
Isolation of Chlamydia pneumoniae from the Coronary Artery of a Patient with Coronary Atherosclerosis
  • Julio Ramirez
  • Medicine
  • Annals of Internal Medicine
  • 1996
TLDR
This study sought to determine, using various diagnostic methods, whether C. pneumoniae was present in the coronary arteries of patients with coronary atherosclerosis, and whether these structures were compatible with Chlamydia organisms. Expand
The atherogenic effects of chlamydia are dependent on serum cholesterol and specific to Chlamydia pneumoniae.
TLDR
Mice with low-density lipoprotein receptor deficiency were induced to develop atherosclerotic lesions in aorta with a cholesterol-enriched diet that increased serum cholesterol by two- to threefold, demonstrating that a hypercholesterolemic condition is required for the C. pneumoniae to aggravate the development of atherosclerosis. Expand
Chlamydia pneumoniae infection induces inflammatory changes in the aortas of rabbits.
TLDR
The results suggest that C. pneumoniae infection is capable of inducing inflammatory atherosclerosis-like changes in the aortas of infected rabbits. Expand
Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model.
TLDR
Intranasal C pneumoniae infection accelerates intimal thickness in rabbits given a modestly cholesterol-enhanced diet and weekly treatment with azithromycin after infectious exposure prevents accelerated intimal thickening. Expand
Antibiotics effects in a rabbit model of Chlamydia pneumoniae-induced atherosclerosis.
  • I. Fong
  • Medicine
  • The Journal of infectious diseases
  • 2000
TLDR
These studies support but do not prove that C. pneumoniae can cause atherosclerosis, but the optimum dose and duration of therapy or use of combination of agents remain to be determined. Expand
Detection of Chlamydia pneumoniae-reactive T lymphocytes in human atherosclerotic plaques of carotid artery.
TLDR
The results suggests that cell-mediated immunity to C pneumoniae plays a role in the atherosclerotic process and that this response may involve autoimmunity. Expand
...
1
2
3
4
5
...